Endoscopic Submucosal Dissection Market Expansion Through Robotic Endoscopy Tools

 The global endoscopic submucosal dissection market size was estimated at USD 391.50 million in 2025 and is projected to reach USD 597.58 million by 2033, growing at a CAGR of 5.40% from 2026 to 2033. The market is experiencing notable growth due to the increasing incidence of gastrointestinal cancers and digestive tract disorders worldwide. Technological advancements in endoscopic systems, imaging solutions, and minimally invasive surgical procedures are significantly contributing to market expansion. The growing preference for organ-preserving treatment procedures and rising awareness regarding early cancer diagnosis are also supporting the adoption of endoscopic submucosal dissection procedures globally.

Key Market Trends & Insights

  • North America endoscopic submucosal dissection market dominated global market in 2025 with a revenue share of 39.73%.
  • The U.S. endoscopic submucosal dissection market accounted for the largest share in North America in 2025.
  • Based on product, the Knives segment held the largest share in 2025.
  • Based on indication, the stomach cancer segment held the largest share in 2025.
  • Based on end use, the hospitals segment held the largest share in 2025.

Market Size & Forecast

  • 2025 Market Size: USD 391.50 Million
  • 2033 Projected Market Size: USD 597.58 Million
  • CAGR (2026-2033): 5.40%
  • North America: Largest market in 2025
  • Asia Pacific: Fastest market in 2025

The rising burden of gastrointestinal malignancies, including stomach, esophageal, and colorectal cancers, continues to increase the demand for effective and minimally invasive treatment procedures. Endoscopic submucosal dissection has emerged as a highly efficient therapeutic approach for the removal of superficial neoplastic lesions from the gastrointestinal tract. The procedure enables en bloc resection of lesions, reducing recurrence rates and improving histopathological assessment. As healthcare systems increasingly prioritize early-stage cancer management and minimally invasive treatments, the demand for ESD procedures is expected to rise steadily during the forecast period.

Download a free sample copy of the Endoscopic Submucosal Dissection Market report to understand detailed coverage and inclusions in the final report

According to the American Cancer Society, in January 2026, there are expected to be 31,510 new cases of stomach cancer, including 13,610 cases among women and 17,900 cases among men. The increasing prevalence of gastric, esophageal, and colorectal cancers worldwide is encouraging healthcare providers to adopt advanced endoscopic procedures such as ESD. The growing need for accurate diagnosis, precise lesion removal, and reduced hospitalization duration is accelerating the utilization of ESD technologies across hospitals and specialized gastrointestinal treatment centers.

The endoscopic submucosal dissection market includes advanced endoscopic procedures mainly designed for the treatment and removal of superficial neoplastic lesions in the gastrointestinal tract, particularly within the esophagus, stomach, and colon. Unlike endoscopic mucosal resection, which is generally suitable for smaller lesions, ESD facilitates the complete resection of larger and more complex lesions through meticulous submucosal dissection techniques. The procedure requires the use of specialized instruments such as ESD knives, injection solutions, electrosurgical devices, hemostatic accessories, and high-definition endoscopes. These advanced tools enable precise tissue removal while preserving organ integrity and improving patient recovery outcomes.

The increasing adoption of minimally invasive procedures is one of the major factors positively influencing market growth. Patients and healthcare providers are increasingly preferring minimally invasive procedures due to shorter recovery periods, reduced postoperative pain, lower complication risks, and improved clinical outcomes. ESD procedures help preserve gastrointestinal organ functionality while effectively removing precancerous or cancerous lesions, making them an attractive alternative to conventional surgical procedures. Furthermore, advancements in imaging technologies and endoscopic visualization systems are improving procedural accuracy and supporting wider adoption among clinicians.

Looking for more specific insights? Customize this report to suite your business needs

Growing investments in healthcare infrastructure and medical technology are also contributing to the expansion of the endoscopic submucosal dissection market. Healthcare institutions are increasingly adopting sophisticated endoscopic systems to improve patient outcomes and enhance procedural efficiency. In addition, rising healthcare expenditure and increasing awareness regarding gastrointestinal cancer screening programs are creating favorable market opportunities. Several governments and healthcare organizations are promoting early cancer detection initiatives, which is expected to further strengthen demand for ESD procedures over the coming years.

The market is also benefiting from continuous product innovation by leading medical device manufacturers. Companies are introducing advanced ESD knives, electrosurgical generators, and high-definition endoscopic imaging systems designed to improve procedural safety and effectiveness. Integration of artificial intelligence and enhanced imaging technologies into endoscopy platforms is further supporting accurate lesion detection and diagnosis. These technological advancements are expected to create new growth avenues for the market during the forecast period.

Explore Grand View Horizon to see global and regional level statistics related to the Endoscopic Submucosal Dissection Market

Key market participants are focusing on implementing various strategic initiatives to strengthen their market position and expand their global presence. These strategies include partnerships, collaborations, mergers and acquisitions, product launches, and geographical expansions. Companies are also investing significantly in research and development activities to introduce technologically advanced products and improve procedural outcomes. The competitive landscape of the market is expected to remain highly dynamic due to ongoing technological advancements and increasing investments in minimally invasive treatment solutions.

Key companies operating in the endoscopic submucosal dissection market include Olympus Corporation, Boston Scientific Corporation, PENTAX Medical (Hoya Corporation), FUJIFILM Holdings Corporation, Karl Storz GmbH & Co. KG, Micro-Tech Endoscopy, Medtronic, CONMED Corporation, STERIS plc., Cook Group, and Creo Medical. These companies are actively focusing on strengthening their product portfolios and expanding their presence in emerging markets to capitalize on growing healthcare demand.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Conclusion

The global endoscopic submucosal dissection market is expected to witness stable growth over the forecast period due to the rising burden of gastrointestinal cancers, increasing adoption of minimally invasive treatment procedures, and continuous advancements in endoscopic technologies. The growing demand for accurate and organ-preserving cancer treatment solutions is encouraging healthcare providers to adopt ESD procedures across hospitals and specialized treatment centers. Technological innovations, expanding healthcare infrastructure, and increasing awareness regarding early cancer diagnosis are expected to create favorable growth opportunities for market participants. Furthermore, strategic initiatives undertaken by leading companies, including product innovation, collaborations, and geographical expansion, are likely to strengthen market competition and support long-term industry growth.

Grand View Research offers

  • Focused market intelligence reports on specific geographies or high-growth segments.
  • Extended forecast timelines for long-term planning.
  • Competitor Benchmarking and Supply Chain Analysis
  • Inclusion of regulatory and policy assessments.
  • Inclusion of custom data models, KPIs, or applications unique to your business
  • Specific high-impact Data Decks and Tables to support effective decision making

And much more…

Browse our new services – Grand View Brainshare

Comments

Post a Comment

Popular posts from this blog

Mobile Device Management Market Thrives with Growth in Cloud-Based Solutions

  According to a recent report by Grand View Research, Inc., the global   mobile device management (MDM) market   is projected to reach USD 28.37 billion by 2030, expanding at a CAGR of 24.5% from 2025 to 2030. This growth is primarily attributed to the increasing use of mobile devices in the workplace and the growing need to manage and secure them effectively. As smartphones, tablets, and other mobile devices become more prevalent, employees are increasingly using their personal devices for work—an approach known as Bring Your Own Device (BYOD). This trend is contributing to the rising number of mobile devices requiring centralized oversight and protection. MDM solutions offer organizations a unified platform to oversee and secure mobile devices, enabling functions such as security policy enforcement, device usage monitoring, and remote data wiping in cases of loss or theft. As companies continue to implement BYOD strategies or issue corporate devices to employees, deman...
Read more

U.S. Interventional Oncology Market Boosted by Aging Population

  The   U.S. interventional oncology market   size was estimated at USD 998.4 million in 2024 and is projected to reach USD 1,597 million by 2030, expanding at a CAGR of 8.17% from 2025 to 2030. This market growth is primarily driven by the increasing prevalence of cancer, continuous technological advancements in minimally invasive treatments, expanding investments in interventional oncology, and the aging population across the U.S. A major contributing factor is the rising incidence of cancer in the country. According to the American Cancer Society, approximately 2,041,910 new cancer cases are expected to be diagnosed in the U.S. in 2025, with 618,120 projected cancer-related deaths. As conventional therapies like chemotherapy and radiation often lead to significant side effects, minimally invasive techniques such as radiofrequency ablation and microwave ablation are becoming more popular. These procedures target tumors precisely while minimizing harm to surrounding tiss...
Read more

HLA Typing Market Fueled by Growing Prevalence of Autoimmune Disorders

  The global   HLA typing market   was valued at USD 1,032.1 million in 2022 and is anticipated to reach USD 1.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030. This market growth is primarily driven by the increasing need for organ transplantation and the extensive application of human leukocyte antigen (HLA) testing in pharmacogenetics. HLA matching remains a critical method for evaluating tissue compatibility in transplantation. It is a mandatory procedure for all organ donors, whether the organs are from deceased individuals, relatives, or unrelated donors. Accurate HLA matching significantly reduces the risk of post-transplant complications. The demand for organ transplants has risen steadily over time. As reported by the Organ Procurement and Transplantation Network, 41,354 organ transplants were performed in the United States alone in 2021—a 5.9% increase compared to 2020. Kidney transplants were the most common, with 24,...
Read more